Paper17845853
The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi.
Cai S and 4 others. Bioorg Med Chem, 2007. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi. Papers, record 17845853. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17845853
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The antiviral drug ribavirin is a selective inhibitor of S-adenosyl-L-homocysteine hydrolase from Trypanosoma cruzi.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosylhomocysteinase | Major topic |
| Antiviral Agents | Major topic |
| Enzyme Inhibitors | Major topic |
| Ribavirin | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Binding Sites | |
| Chromatography, High Pressure Liquid | |
| Drug Design | |
| Enzyme Activation | |
| Humans | |
| Kinetics | |
| Molecular Conformation | |
| NAD | |
| Recombinant Proteins | |
| Spectrometry, Mass, Electrospray Ionization | |
| Structure-Activity Relationship | |
| Time Factors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM029332 | NIGMS NIH HHS | United States | R01GM029332 | PubMed and NIH |
| GM-29332 | NIGMS NIH HHS | United States | R01GM029332 | PubMed and NIH |
Source NIH RePORTER
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11185563 | Overexpression, purification, and characterization of S-adenosylhomocysteine hydrolase from Leishmania donovani. | Arch Biochem Biophys | 2000 | https://conductscience.org/library/papers/11185563 | PubMed |
| 2 | 17447732 | Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 1. Basic features of the association and dissociation processes. | Biochemistry | 2007 | https://conductscience.org/library/papers/17447732 | PubMed |
| 3 | 12590576 | Catalytic strategy of S-adenosyl-L-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions. | Biochemistry | 2003 | https://conductscience.org/library/papers/12590576 | PubMed |
| 4 | 14969692 | Trypanosoma cruzi: molecular cloning and characterization of the S-adenosylhomocysteine hydrolase. | Exp Parasitol | 2003 | https://conductscience.org/library/papers/14969692 | PubMed |
| 5 | 15037606 | The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. | J Biol Chem | 2004 | https://conductscience.org/library/papers/15037606 | PubMed |
| 6 | 762125 | The mechanism of action of S-adenosylhomocysteinase. | J Biol Chem | 1979 | https://conductscience.org/library/papers/762125 | PubMed |
| 7 | 2910349 | Rat liver S-adenosylhomocysteinase. Spectrophotometric study of coenzyme binding. | Biochim Biophys Acta | 1989 | https://conductscience.org/library/papers/2910349 | PubMed |
| 8 | 2033576 | S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy. | J Med Chem | 1991 | https://conductscience.org/library/papers/2033576 | PubMed |
| 9 | 8206944 | Plasmodium falciparum S-adenosylhomocysteine hydrolase. cDNA identification, predicted protein sequence, and expression in Escherichia coli. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8206944 | PubMed |
| 10 | 8093102 | Effects of novel anti-viral adenosine analogues on the activity of S-adenosylhomocysteine hydrolase from human liver. | Biochem Pharmacol | 1994 | https://conductscience.org/library/papers/8093102 | PubMed |
| 11 | 8910410 | Chemical modification and site-directed mutagenesis of cysteine residues in human placental S-adenosylhomocysteine hydrolase. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8910410 | PubMed |
| 12 | 9578320 | Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. | Pharmacol Ther | 1998 | https://conductscience.org/library/papers/9578320 | PubMed |
| 13 | 9586999 | Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. | Nat Struct Biol | 1998 | https://conductscience.org/library/papers/9586999 | PubMed |
| 14 | 10387078 | Crystal structure of S-adenosylhomocysteine hydrolase from rat liver. | Biochemistry | 1999 | https://conductscience.org/library/papers/10387078 | PubMed |
| 15 | 17148699 | Chagas disease. | Postgrad Med J | 2006 | https://conductscience.org/library/papers/17148699 | PubMed |
| 16 | 11325033 | Structure and function of S-adenosylhomocysteine hydrolase. | Cell Biochem Biophys | 2000 | https://conductscience.org/library/papers/11325033 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42446680 | Synthesis and structure-activity relationship studies of 1,2,4-triazole-benzoxazepine hybrids as α-glucosidase inhibitors: molecular docking and biological evaluation. | Med Chem Res | 2026 | https://conductscience.org/library/papers/42446680 | PubMed |
| 41568342 | S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41568342 | PubMed |
| 39948258 | In-silico Study of an Inhibitor of S-Adenosyl-L-Homocysteine Hydrolase (SAHH) of Naegleria fowleri using Molecular Docking, Density Functional Theory (DFT), and Molecular Dynamics (MD) Simulation. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/39948258 | PubMed |
| 38279895 | Targeting one-carbon metabolism for cancer immunotherapy. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/38279895 | PubMed |
| 38008942 | A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles. | Mini Rev Med Chem | 2024 | https://conductscience.org/library/papers/38008942 | PubMed |
| 33760815 | Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba. | PLoS One | 2021 | https://conductscience.org/library/papers/33760815 | PubMed |
| 32635156 | Chemistry and Biological Activities of 1,2,4-Triazolethiones-Antiviral and Anti-Infective Drugs. | Molecules | 2020 | https://conductscience.org/library/papers/32635156 | PubMed |
| 31939725 | Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder. | Curr Pharm Des | 2020 | https://conductscience.org/library/papers/31939725 | PubMed |
| 26573329 | Structural insights into the reaction mechanism of S-adenosyl-L-homocysteine hydrolase. | Sci Rep | 2015 | https://conductscience.org/library/papers/26573329 | PubMed |
| 25521119 | Design and synthesis of a series of truncated neplanocin fleximers. | Molecules | 2014 | https://conductscience.org/library/papers/25521119 | PubMed |
| 25248746 | Regulation of S-adenosylhomocysteine hydrolase by lysine acetylation. | J Biol Chem | 2014 | https://conductscience.org/library/papers/25248746 | PubMed |
| 23807823 | Antimicrobial and antiurease activities of newly synthesized morpholine derivatives containing an azole nucleus. | Med Chem Res | 2013 | https://conductscience.org/library/papers/23807823 | PubMed |
| 20687591 | Comparative kinetics of cofactor association and dissociation for the human and trypanosomal S-adenosylhomocysteine hydrolases. 3. Role of lysyl and tyrosyl residues of the C-terminal extension. | Biochemistry | 2010 | https://conductscience.org/library/papers/20687591 | PubMed |
| 20183598 | The rationale for targeting the NAD/NADH cofactor binding site of parasitic S-adenosyl-L-homocysteine hydrolase for the design of anti-parasitic drugs. | Nucleosides Nucleotides Nucleic Acids | 2009 | https://conductscience.org/library/papers/20183598 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AHCY | 191 | PubTator's text mining | https://conductscience.org/library/genes/191 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17845853
GET https://conductscience.org/api/papers/v1/17845853/authors